Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chromogranin A assay in clinical practice.
d'Herbomez M, Do Cao C, Vezzosi D, Borzon-Chasot F, Baudin E; groupe des tumeurs endocrines (GTE France). d'Herbomez M, et al. Among authors: vezzosi d. Ann Endocrinol (Paris). 2010 Sep;71(4):274-80. doi: 10.1016/j.ando.2010.04.004. Epub 2010 Jun 9. Ann Endocrinol (Paris). 2010. PMID: 20538257 Review.
Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up study.
Vezzosi D, Walter T, Laplanche A, Raoul JL, Dromain C, Ruszniewski P, d'Herbomez M, Guigay J, Mitry E, Cadiot G, Leboulleux S, Lombard-Bohas C, Borson-Chazot F, Ducreux M, Baudin E. Vezzosi D, et al. Among authors: d herbomez m. Int J Biol Markers. 2011 Apr-Jun;26(2):94-101. doi: 10.5301/JBM.2011.8327. Int J Biol Markers. 2011. PMID: 21574156 Free article.
Fast test: clinical practice and interpretation.
Agin A, Charrie A, Chikh K, Tabarin A, Vezzosi D; French Endocrine Society. Agin A, et al. Among authors: vezzosi d. Ann Endocrinol (Paris). 2013 Jul;74(3):174-84. doi: 10.1016/j.ando.2013.05.003. Epub 2013 Jun 19. Ann Endocrinol (Paris). 2013. PMID: 23790314 No abstract available.
One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma.
Hescot S, Leboulleux S, Amar L, Vezzosi D, Borget I, Bournaud-Salinas C, de la Fouchardiere C, Libé R, Do Cao C, Niccoli P, Tabarin A, Raingeard I, Chougnet C, Giraud S, Gimenez-Roqueplo AP, Young J, Borson-Chazot F, Bertherat J, Wemeau JL, Bertagna X, Plouin PF, Schlumberger M, Baudin E; French group of Endocrine and Adrenal tumors (Groupe des Tumeurs Endocrines-REseau NAtional des Tumeurs ENdocrines and COrtico-MEdullo Tumeurs Endocrines networks). Hescot S, et al. Among authors: vezzosi d. J Clin Endocrinol Metab. 2013 Oct;98(10):4006-12. doi: 10.1210/jc.2013-1907. Epub 2013 Jul 24. J Clin Endocrinol Metab. 2013. PMID: 23884775
Malignant insulinoma: recommendations for characterisation and treatment.
Baudin E, Caron P, Lombard-Bohas C, Tabarin A, Mitry E, Reznick Y, Taieb D, Pattou F, Goudet P, Vezzosi D, Scoazec JY, Cadiot G, Borson-Chazot F, Do Cao C; Société française d’endocrinologie; Groupe d’étude des tumeurs endocrines. Baudin E, et al. Among authors: vezzosi d. Ann Endocrinol (Paris). 2013 Dec;74(5-6):523-33. doi: 10.1016/j.ando.2013.07.001. Epub 2013 Aug 27. Ann Endocrinol (Paris). 2013. PMID: 23993836 Free article. No abstract available.
[Malignant insulinoma: recommendations for workup and treatment].
Baudin E, Caron P, Lombard-Bohas C, Tabarin A, Mitry E, Reznick Y, Taieb D, Pattou F, Goudet P, Vezzosi D, Scoazec JY, Cadiot G, Borson-Chazot F, Do Cao C; pour la Société française d’endocrinologie et le Groupe d’étude des tumeurs endocrines. Baudin E, et al. Among authors: vezzosi d. Presse Med. 2014 Jun;43(6 Pt 1):645-59. doi: 10.1016/j.lpm.2013.08.007. Epub 2014 May 21. Presse Med. 2014. PMID: 24857257 French.
p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation?
Nozières C, Zhang CX, Buffet A, Dupasquier S, Vargas-Poussou R, Guillaud-Bataille M, Cordier-Bussat M, Ruszniewski P, Christin-Maitre S, Murat A, Groussin L, Vezzosi D, Cardot-Bauters C, Hervieu V, Joly MO, Giraud S, Odou MF, Gimenez-Roqueplo AP, Goudet P, Borson-Chazot F, Calender A; Groupe français des tumeurs endocrines (GTE). Nozières C, et al. Among authors: vezzosi d. Ann Endocrinol (Paris). 2014 Jul;75(3):133-40. doi: 10.1016/j.ando.2014.05.003. Epub 2014 Jul 2. Ann Endocrinol (Paris). 2014. PMID: 24997771
Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d'étude des Tumeurs Endocrines (GTE) retrospective study.
Vezzosi D, Cardot-Bauters C, Bouscaren N, Lebras M, Bertholon-Grégoire M, Niccoli P, Levy-Bohbot N, Groussin L, Bouchard P, Tabarin A, Chanson P, Lecomte P, Guilhem I, Carrere N, Mirallié E, Pattou F, Peix JL, Goere D, Borson-Chazot F, Caron P, Bongard V, Carnaille B, Goudet P, Baudin E. Vezzosi D, et al. Eur J Endocrinol. 2015 Mar;172(3):309-19. doi: 10.1530/EJE-14-0878. Epub 2014 Dec 23. Eur J Endocrinol. 2015. PMID: 25538206
Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors.
Vezzosi D, Do Cao C, Hescot S, Bertherat J, Haissaguerre M, Bongard V, Drui D, De La Fouchardière C, Illouz F, Borson-Chazot F, Djobo B, Berdelou A, Tabarin A, Schlumberger M, Briet C, Caron P, Leboulleux S, Libe R, Baudin E; For Comete-Cancer Network. Vezzosi D, et al. Horm Cancer. 2018 Feb;9(1):62-69. doi: 10.1007/s12672-017-0313-6. Epub 2017 Oct 25. Horm Cancer. 2018. PMID: 29071575 Free PMC article.
Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation.
Renaudin K, Smati S, Wargny M, Al Ghuzlan A, Aubert S, Leteurtre E, Patey M, Sibony M, Sturm N, Tissier F, Amar L, Bertherat J, Berthozat C, Chabre O, Do Cao C, Haissaguerre M, Pierre P, Briet C, Vezzosi D, Lifante JC, Pattou F, Mirallie E, Baudin E, Cariou B, Libe R, Drui D; for Comete-Cancer Network. Renaudin K, et al. Among authors: vezzosi d. Mod Pathol. 2018 Nov;31(11):1708-1716. doi: 10.1038/s41379-018-0077-8. Epub 2018 Jun 19. Mod Pathol. 2018. PMID: 29921900 Free article.
86 results